The New York Academic Consortium (NYAC) is comprised of the licensing and business development offices of the seven largest biomedical institutions in New York City. NYAC members work together to develop and share the best practices that have made NYC one of the leading sources of pharmaceutical and biotechnology products and innovation.
Key 2007 Achievements at NYAC Institutions
Research Funds: $1.9 billion
Number of Inventions: 643
New Licenses and Options: 193
Gross Licensing Revenue: $509 million
Number of New Start-up Companies: 20
Total Active Revenue Generating Agreements: 566
Number of Start-up Companies to Date: 188
For additional information please refer to the contact information provided in the attached NYAC brochure.